8-KShareholder Matters

ELI LILLY & Co 8-K Report, Shareholder Vote Results (May 6, 2016)

Filed May 6, 2016For Securities:LLY

Summary

Eli Lilly and Company (LLY) filed a Form 8-K on May 5, 2016, reporting preliminary results from its annual shareholder meeting held on May 2, 2016. The filing primarily details the voting outcomes on key corporate governance matters, including the election of directors, advisory approval of executive compensation, and the ratification of the independent auditor. Investors can find reassurance in the strong support for the board of directors and the ratification of Ernst & Young as the auditor, indicating general shareholder confidence in the company's governance and financial oversight. Of note, the company also reported that a shareholder proposal requesting a report on country selection for operations or investments was not approved, indicating that the majority of shareholders did not support this specific information request at this time. The filing notes that these are preliminary results and final voting figures will be disclosed in an amendment to the 8-K.

Key Highlights

  • 1The annual shareholder meeting for Eli Lilly and Company was held on May 2, 2016.
  • 2Five nominees for the Board of Directors were elected to serve three-year terms ending in 2019, with substantial 'For' votes.
  • 3Shareholders provided an advisory 'Say-on-Pay' vote, with a significant majority approving the compensation paid to named executive officers.
  • 4Ernst & Young was ratified as the principal independent auditor for the company, receiving strong shareholder support.
  • 5A shareholder proposal requesting a report on the criteria for selecting countries for operations or investments was not approved.
  • 6The company reported preliminary voting results and will file an amendment with final results.
  • 7As of the record date, there were 1,104,492,346 shares of common stock issued and outstanding.

Frequently Asked Questions

This Form 8-K filing was made to report the preliminary voting results from Eli Lilly and Company's annual meeting of shareholders held on May 2, 2016. It covers the outcomes of votes on director elections, executive compensation, auditor ratification, and shareholder proposals.

The five nominees for the Board of Directors received a strong majority of votes 'For' their election to three-year terms. For example, R. David Hoover received approximately 780.9 million 'For' votes out of a total of roughly 800 million voting shares. This indicates broad shareholder support for the current board.

Shareholders approved, on an advisory basis, the compensation paid to the company's named executive officers. The vote was heavily in favor, with approximately 770.5 million 'For' votes compared to about 13.7 million 'Against' votes.

Yes, the appointment of Ernst & Young as Eli Lilly's principal independent auditor was ratified by shareholders. This received overwhelming support, with over 879.7 million 'For' votes.

A shareholder proposal that sought a report on how the company selects countries for its operations or investments was not approved. The 'Against' vote significantly outnumbered the 'For' vote, indicating shareholders did not support this particular information request at this time.